Navigation Links
Treatment over a longer period for blood clotting

Venous thromboembolism is a condition which causes clotting in the veins. Typical therapy for venous thromboembolism includes a five- to 10-day course of heparin followed by three to 12 months of the oral drug warfarin. However, the problem with this treatment is that once the patient goes off warfarin, venous thromboembolism recurs. While recurrence rates of this problem are reduced if the patient stays on warfarin, according to previous studies, it// also puts the patient at an increased risk for a major hemorrhage. Researchers have now conducted a study to find out whether keeping patients on a low-dose of warfarin would be beneficial or too much of a risk.

The study included more than 500 patients who received standard treatment and then were assigned to receive a placebo or low-intensity warfarin. Participants were followed to see who had recurrent venous thromboembolism, major hemorrhage, and who died. After four years, researchers found that 37 of the 253 patients assigned to the placebo had recurrent venous thromboembolism, as compared with 14 of the 255 patients on the low-intensity warfarin. This indicated a risk reduction of 64 percent. Furthermore, major hemorrhage occurred in two patients on the placebo and five on the warfarin. Researchers claimed that the reduction in the risk of recurrent venous thromboembolism for patients on low-intensity warfarin, after adjusting for other factors, was between 76 percent and 81 percent.

Andrew Schafer, M.D., from the University of Pennsylvania School of Medicine, in an accompanying editorial said that though researchers claim short-term treatment reduces the risk of recurrent venous thromboembolism by up to 81 percent, doctors are continuing to walk a tightrope for dosing medicine for patients with venous thromboembolism. Although low-intensity warfarin may prevent recurrent venous thromboembolism it is unclear what dosage doctors need to give to prevent recurrence and not cause major bleedin g.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... , ... February 05, 2016 , ... The American public ... such water may be safer than regular municipal or well water. The recent experience ... host Sharon Kleyne, could go a long way toward increasing public acceptance of recycled ...
(Date:2/5/2016)... Dallas, Texas (PRWEB) , ... February 05, 2016 , ... ... to allow users to search for and donate to Give To Cure’s campaign ... is an app that lets users make and share payments through a smart device. ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point Consulting, ... in KLAS: Software & Services for HIT Implementation Support & Staffing report with ... ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 hospitals ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. Lydia Muccioli of ... Dental Day to individuals in need. The event is scheduled to take place on ... Day is to provide dental care to community members in need. Each patient will ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... of CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, ... offers a complete range of oral health care, including general dentistry, cosmetic treatments, ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 For hospitals considering ... those already participating in the program, the Health Resources ... to as the , Mega-Guidance , could have significant ... is published in September 2016. Essential Insights ... Service Marketing , summarizes the Mega-Guidance,s key proposed changes, ...
(Date:2/4/2016)... Feb. 4, 2016  The Senior Care Pharmacy ... Reform Committee Chairman Jason Chaffetz (R-UT) ... today,s hearing , "Developments in the Prescription ... and growing questions about abusive pharmacy benefit manager ... (R-UT) and Ranking Member Elijah Cummings (D-MD) are ...
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
Breaking Medicine Technology: